ARROWHEAD PHARMACEUTICALS, INC. Quarterly Common Stock, Shares Authorized from Q3 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Arrowhead Pharmaceuticals, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q3 2010 to Q3 2024.
  • Arrowhead Pharmaceuticals, Inc. Common Stock, Shares Authorized for the quarter ending September 30, 2024 was 290M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 290M 0 0% Sep 30, 2024 10-K 2024-11-26
Q2 2024 290M 0 0% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 290M 0 0% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 290M +145M +100% Dec 31, 2023 10-Q 2024-02-06
Q3 2023 290M +145M +100% Sep 30, 2023 10-K 2024-11-26
Q2 2023 290M +145M +100% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 290M +145M +100% Mar 31, 2023 10-Q 2023-05-02
Q4 2022 145M 0 0% Dec 31, 2022 10-Q 2023-02-06
Q3 2022 145M 0 0% Sep 30, 2022 10-K 2023-11-29
Q2 2022 145M 0 0% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 145M 0 0% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 145M 0 0% Dec 31, 2021 10-Q 2022-02-02
Q3 2021 145M 0 0% Sep 30, 2021 10-K 2022-11-28
Q2 2021 145M 0 0% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 145M 0 0% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 145M 0 0% Dec 31, 2020 10-Q 2021-02-04
Q3 2020 145M 0 0% Sep 30, 2020 10-K 2021-11-22
Q2 2020 145M 0 0% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 145M 0 0% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 145M 0 0% Dec 31, 2019 10-Q 2020-02-05
Q3 2019 145M 0 0% Sep 30, 2019 10-K 2020-11-23
Q2 2019 145M 0 0% Jun 30, 2019 10-Q 2019-08-05
Q1 2019 145M 0 0% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 145M 0 0% Dec 31, 2018 10-Q 2019-02-07
Q3 2018 145M 0 0% Sep 30, 2018 10-K 2019-11-25
Q2 2018 145M 0 0% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 145M 0 0% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 145M 0 0% Dec 31, 2017 10-Q 2018-02-09
Q3 2017 145M 0 0% Sep 30, 2017 10-K 2018-12-11
Q2 2017 145M 0 0% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 145M 0 0% Mar 31, 2017 10-Q 2017-05-03
Q4 2016 145M 0 0% Dec 31, 2016 10-Q 2017-02-06
Q3 2016 145M 0 0% Sep 30, 2016 10-K 2017-12-12
Q2 2016 145M 0 0% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 145M 0 0% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 145M 0 0% Dec 31, 2015 10-Q 2016-02-09
Q3 2015 145M 0 0% Sep 30, 2015 10-K 2016-12-14
Q2 2015 145M 0 0% Jun 30, 2015 10-Q 2015-08-04
Q1 2015 145M 0 0% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 145M 0 0% Dec 31, 2014 10-Q 2015-02-09
Q3 2014 145M 0 0% Sep 30, 2014 10-K 2015-12-14
Q2 2014 145M 0 0% Jun 30, 2014 10-Q 2014-08-12
Q1 2014 145M 0 0% Mar 31, 2014 10-Q 2014-05-06
Q4 2013 145M 0 0% Dec 31, 2013 10-Q 2014-02-04
Q3 2013 145M 0 0% Sep 30, 2013 10-K 2014-11-25
Q2 2013 145M 0 0% Jun 30, 2013 10-Q 2013-08-07
Q1 2013 145M 0 0% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 145M 0 0% Dec 31, 2012 10-Q 2013-02-13
Q3 2012 145M 0 0% Sep 30, 2012 10-K 2013-12-18
Q2 2012 145M 0 0% Jun 30, 2012 10-Q 2012-08-13
Q1 2012 145M Mar 31, 2012 10-Q 2012-05-08
Q4 2011 145M Dec 31, 2011 10-Q 2012-02-09
Q3 2011 145M 0 0% Sep 30, 2011 10-K 2012-12-28
Q2 2011 145M Jun 30, 2011 10-Q 2011-08-08
Q3 2010 145M Sep 30, 2010 10-K 2011-12-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.